What Is Fetal Fraction and What Do Low Results Mean?

Fetal fraction is the percentage of cell-free DNA in a pregnant person’s blood that comes from the pregnancy, as opposed to the parent’s own cells. It matters because noninvasive prenatal testing (NIPT) reads that DNA to screen for chromosomal conditions, and the test needs enough pregnancy-derived DNA in the sample to produce a reliable result. When fetal fraction is too low, the lab may report the screen as “no result” or “test failure,” which can be alarming but doesn’t automatically mean something is wrong with the baby.

Where “Fetal” DNA Actually Comes From

The name is a bit misleading. The cell-free DNA that NIPT analyzes isn’t shed directly by the fetus. It comes from the placenta, specifically from the outer layer of placental cells called the trophoblast, which constantly turns over and releases fragments of DNA into the pregnant person’s bloodstream.¹ Those fragments mix with the much larger pool of cell-free DNA that the parent’s own body releases from normal cell breakdown. The proportion of that total pool attributable to the placenta is the fetal fraction.

Because the DNA is placental rather than truly fetal, anything that changes how the placenta grows or sheds cells can shift fetal fraction up or down. And anything that changes the amount of the parent’s own circulating DNA can dilute the placental contribution, even if the placenta itself is perfectly healthy. This distinction between source and dilution explains most of the reasons fetal fraction varies from person to person.

How Fetal Fraction Is Measured

Labs don’t measure fetal fraction with a single straightforward test. Several methods exist, and they rely on different biological signals. Some look at DNA methylation patterns, since placental DNA and maternal DNA are chemically marked differently. Others count fragments from the Y chromosome (which works only if the fetus is male) or use machine-learning algorithms that analyze fragment-length distributions, since placental DNA fragments tend to be shorter than maternal ones.² One newer approach uses differentially methylated regions of the genome with digital droplet PCR to get a precise read.³

The practical takeaway is that fetal fraction isn’t one universal number stamped the same way by every lab. Different platforms may report slightly different values for the same blood sample, depending on their measurement approach. Most labs set a minimum threshold, commonly around 4%, below which they won’t issue a screening result because accuracy drops too far.

What Counts as “Low” and Why the Threshold Matters

NIPT works by looking for tiny statistical imbalances in chromosomal DNA. If chromosome 21 material makes up a slightly larger share of the cell-free DNA than expected, that suggests the fetus may have an extra copy of chromosome 21 (Down syndrome). But detecting that signal requires enough placental DNA in the mix. When fetal fraction falls below the lab’s cutoff, the signal-to-noise ratio becomes too poor to call confidently, and the lab reports a “no call” or inconclusive result.

The exact minimum threshold depends on the condition being screened for and the sequencing method. One study using low-depth whole-genome sequencing determined that a fetal fraction of at least 5% was needed for 100% detection of trisomy 21.⁴ Other conditions with subtler chromosomal shifts may need even higher fractions. So while 4% is a commonly cited clinical cutoff, it’s not a magic number that applies universally across all platforms or all conditions.

The Biggest Reasons Fetal Fraction Runs Low

Two factors dominate: how far along the pregnancy is and the parent’s body mass index.

Gestational age has a clear positive relationship with fetal fraction. The placenta grows rapidly in the first trimester, releasing more DNA as it expands. Testing before 10 weeks tends to yield lower fetal fractions than testing at 10 weeks or later, and the difference is significant even after adjusting for other factors like age and BMI.⁵ This is a major reason most guidelines recommend NIPT from 10 weeks onward. Drawing blood a week or two earlier doesn’t just risk a slightly lower number; it meaningfully raises the chance of getting no result at all.

Higher maternal BMI consistently lowers fetal fraction, and the mechanism isn’t simply that a bigger body produces more blood to dilute the placental DNA. Research shows the total amount of cell-free DNA in the blood doesn’t differ much between people of normal weight and those who are obese.⁶ Instead, the issue seems to be that adipose tissue itself sheds extra cell-free DNA through cell turnover. That flood of maternal DNA from fat cells dilutes the placental contribution, driving fetal fraction down even though total DNA levels look normal.⁷ Increased blood volume in higher-BMI pregnancies may also play a role.⁸

Less Obvious Factors That Can Lower Fetal Fraction

BMI and timing get the most attention, but other medical factors can matter. In one study, people with autoimmune diseases had an average fetal fraction roughly two percentage points lower than matched controls, which is enough to push borderline results below the reporting threshold.⁹ The mechanism isn’t fully understood, but autoimmune conditions involve chronic inflammation and increased cell turnover, which could elevate the parent’s own cell-free DNA and dilute the placental fraction.

Anticoagulant use has also been linked to lower fetal fraction and higher rates of inconclusive NIPT results.¹⁰ If you’re on blood thinners during pregnancy and receive a “no result” on NIPT, this may be a contributing factor worth discussing with your care team. Shorter cfDNA fragments from the placenta may behave differently with certain sequencing methods, and some labs are exploring whether analyzing shorter fragments can improve fetal fraction estimates for people with higher BMI or earlier gestational ages.¹¹

When Low Fetal Fraction Itself Is a Warning Sign

Here is where the story gets more clinically important. Low fetal fraction isn’t always just a technical inconvenience. A large meta-analysis found that pregnancies with low fetal fraction had significantly higher odds of certain chromosomal conditions: the risk of trisomy 13 was about six times higher, trisomy 18 about four and a half times higher, monosomy X (Turner syndrome) about six times higher, and triploidy over 36 times higher compared to pregnancies with normal fetal fraction.¹² Interestingly, trisomy 21 (Down syndrome) did not show this association, likely because a third copy of chromosome 21 doesn’t shrink the placenta the way other aneuploidies do.

The explanation ties back to the placental origin of the DNA. Conditions like trisomy 13, trisomy 18, and triploidy often produce smaller, less functional placentas. A smaller placenta sheds less DNA, which directly reduces fetal fraction.¹³ So the low fetal fraction isn’t just masking a condition that happens to be there; it’s being caused by the condition. This is why some providers treat a “no result” due to low fetal fraction as more than a request to simply redraw blood. It can be a clinically meaningful data point in its own right.

Low Fetal Fraction and Pregnancy Complications

Beyond chromosomal conditions, low fetal fraction has been linked to certain pregnancy complications that involve the placenta. A systematic review found associations between low fetal fraction and hypertensive disease of pregnancy, small-for-gestational-age babies, and preterm birth.¹⁴ One study reported that low fetal fraction was associated with roughly 1.6 times the risk of placental compromise and a 3.3 times higher risk of preeclampsia with severe features.¹⁵

Research also suggests that the lower the fetal fraction, the higher the risk for early-onset preeclampsia and fetal growth restriction, though the evidence isn’t yet strong enough for low fetal fraction to serve as a standalone screening marker for these complications.¹⁶ Think of it as an early clue, not a diagnosis. If your NIPT comes back with a low fetal fraction and you have other risk factors for preeclampsia, your provider might consider closer monitoring later in pregnancy.

What Happens After a “No Result”

Getting a “no call” or “test failure” due to low fetal fraction is more common than many people expect, and the next steps depend on context. The most common recommendation is to redraw blood a week or two later, giving the placenta more time to grow and release DNA. Studies show this works for a large majority of people: in one cohort, roughly 84% of redraws produced an informative result.¹⁷ Higher maternal weight and twin pregnancies were more common among those who failed on the first draw, consistent with the dilution effects described above.

Some people worry that a failed result means the baby is more likely to have a chromosomal condition. The reassuring finding from several studies is that the vast majority of people who fail NIPT due to low fetal fraction and then get a successful redraw have normal results. One study found that among those who initially failed with fetal fraction below 4%, the rate of trisomy was not significantly different from the rate in people who passed on their first draw.¹⁸ That said, not all low fetal fraction failures carry the same level of reassurance. Some providers use algorithms that incorporate fetal fraction alongside other risk factors to determine whether a patient with a “no call” result has a meaningfully elevated risk for specific conditions like trisomy 13 or triploidy, or whether the failure was almost certainly driven by maternal factors like BMI.¹⁹

For people with persistently low fetal fraction on a second draw, or for those whose clinical picture raises concern, diagnostic testing such as amniocentesis or chorionic villus sampling may be recommended. These procedures analyze fetal or placental cells directly rather than relying on circulating DNA fragments, so fetal fraction is not a factor in their accuracy.

Twin Pregnancies and Fetal Fraction

Twin pregnancies add a layer of complexity. In fraternal (dizygotic) twins, each baby has its own placenta, and each placenta contributes DNA to the maternal bloodstream independently. The fetal fraction that matters isn’t the combined total from both placentas but the individual contribution from each. If one twin’s placenta is releasing very little DNA, the screen could miss a condition in that twin even while the overall fetal fraction looks adequate. Labs offering NIPT for twin pregnancies can measure individual fetal fractions in dizygotic twins to make sure both are high enough for a reliable screen.²⁰

In identical (monozygotic) twins sharing a single placenta, the situation is more straightforward: both fetuses are genetically identical, so the combined fetal fraction represents both. The challenge with identical twins is other complications like twin-to-twin transfusion syndrome, which falls outside the scope of fetal fraction but underscores that NIPT in multiple pregnancies requires different interpretation than in singletons.

Fetal Fraction Enrichment and What’s Changing

One of the more promising developments in prenatal screening is the ability to artificially boost fetal fraction before analysis. Because placental DNA fragments tend to be shorter than maternal DNA fragments, labs can selectively sequence fragments in a narrow size range to concentrate the placental signal. A recent large-cohort study used this approach, selecting fragments between 130 and 140 base pairs long, and raised the median fetal fraction to about 24% across more than 10,000 singleton pregnancies.²¹ With that higher signal, the researchers were able to detect much smaller chromosomal deletions and duplications than standard NIPT can pick up.

Fetal fraction enrichment has also shown promise in early pregnancy loss, where fetal fraction often drops too low for standard NIPT to work. In one study, applying enrichment methods pushed detection sensitivity for aneuploidy from about 63% to 100% in the same group of patients.²² These techniques are still making their way into routine clinical use, but they address one of the fundamental limitations of current NIPT: the test’s dependency on having enough placental DNA to work with.

For people with higher BMI or those who need early screening, enrichment methods could eventually reduce the rate of failed tests and the anxiety that comes with repeated blood draws. They could also expand the scope of what NIPT can screen for, pushing beyond the major trisomies into smaller chromosomal changes that currently require invasive testing to detect. How quickly these advances reach standard care will depend on validation studies and whether labs adopt the necessary sequencing protocols, but the direction of the field is clearly toward making fetal fraction less of a bottleneck.

Why Your Provider Might Not Explain All of This

One frustration many people encounter is that NIPT is often presented as a simple blood test with a yes-or-no answer, when the reality is more layered. Fetal fraction is rarely discussed during pre-test counseling, which means a “no result” can feel like it came out of nowhere. Understanding that the test depends on a biological variable influenced by your body, your gestational timing, and the placenta itself can help reframe the experience.

If you receive a low fetal fraction result, a few questions are worth raising with your provider. Was the blood drawn before 10 weeks? Could BMI or medication use be contributing? Does the lab use an algorithm that assigns risk based on fetal fraction patterns, or does it simply report a pass or fail? And if a redraw is recommended, how long should you wait for the best chance of a usable result? These aren’t questions that change the biology, but they can change how you and your provider interpret the result and decide on next steps. Genetic counselors, when available, are particularly well-equipped to walk through these nuances in the context of your individual pregnancy.